Saudi guidelines for testing and treatment of latent tuberculosis infection
- PMID: 20103957
- PMCID: PMC2850181
- DOI: 10.4103/0256-4947.59373
Saudi guidelines for testing and treatment of latent tuberculosis infection
Abstract
Pulmonary tuberculosis is a common disease in Saudi Arabia. As most cases of tuberculosis are due to reactivation of latent infection, identification of individuals with latent tuberculosis infection (LTBI) who are at increased risk of progression to active disease, is a key element of tuberculosis control programs. Whereas general screening of individuals for LTBI is not cost-effective, targeted testing of individuals at high risk of disease progression is the right approach. Treatment of those patients with LTBI can diminish the risk of progression to active tuberculosis disease in the majority of treated patients. This statement is the first Saudi guideline for testing and treatment of LTBI and is a result of the cooperative efforts of four local Saudi scientific societies. This Guideline is intended to provide physicians and allied health workers in Saudi Arabia with the standard of care for testing and treatment of LTBI.
Similar articles
-
Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.Ann Saudi Med. 2018 Mar-Apr;38(2):90-96. doi: 10.5144/0256-4947.2018.90. Ann Saudi Med. 2018. PMID: 29620541 Free PMC article.
-
Compliance with postexposure screening and treatment of latent tuberculosis infection among healthcare workers in a tertiary care hospital in Saudi Arabia.Infect Control Hosp Epidemiol. 2014 Feb;35(2):176-81. doi: 10.1086/674855. Epub 2013 Dec 13. Infect Control Hosp Epidemiol. 2014. PMID: 24442081
-
Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors.Ann Saudi Med. 2020 May-Jun;40(3):191-199. doi: 10.5144/0256-4947.2020.191. Epub 2020 Jun 4. Ann Saudi Med. 2020. PMID: 32493098 Free PMC article.
-
Tuberculosis in Saudi Arabia: can we change the way we deal with the disease?J Infect Public Health. 2010;3(1):17-24. doi: 10.1016/j.jiph.2009.12.001. Epub 2010 Feb 16. J Infect Public Health. 2010. PMID: 20701887 Review.
-
[Guidelines for positive tuberculin test].Arch Pediatr. 2003 Dec;10(12):1109-12. doi: 10.1016/j.arcped.2003.08.005. Arch Pediatr. 2003. PMID: 14643553 Review. French.
Cited by
-
Diagnostic Utility of QuantiFERON-TB Gold (QFT-G) in Active Pulmonary Tuberculosis.J Glob Infect Dis. 2015 Jul-Sep;7(3):108-12. doi: 10.4103/0974-777X.162231. J Glob Infect Dis. 2015. PMID: 26392718 Free PMC article.
-
Knowledge, attitude and practice towards tuberculosis among healthcare and non-healthcare students at a public university in Saudi Arabia.Front Public Health. 2024 Feb 5;12:1348975. doi: 10.3389/fpubh.2024.1348975. eCollection 2024. Front Public Health. 2024. PMID: 38379677 Free PMC article.
-
Monitoring the effect of TNF-alpha inhibitors on laboratory parameters and adverse effects in different diseases: a retrospective, single-center study.Ann Saudi Med. 2022 Sep-Oct;42(5):309-318. doi: 10.5144/0256-4947.2022.309. Epub 2022 Oct 6. Ann Saudi Med. 2022. PMID: 36252145 Free PMC article.
-
Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines.BMJ Open. 2018 Sep 12;8(9):e022445. doi: 10.1136/bmjopen-2018-022445. BMJ Open. 2018. PMID: 30209157 Free PMC article.
-
Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.Ann Saudi Med. 2018 Mar-Apr;38(2):90-96. doi: 10.5144/0256-4947.2018.90. Ann Saudi Med. 2018. PMID: 29620541 Free PMC article.
References
-
- McKenna MT, McCray E, Onorato I. The epidemiology of tuberculosis among foreign-born persons in the United States, 1986 to 1993. N Engl J Med. 1995;332:1071–6. - PubMed
-
- Reichman LB. Tuberculin skin testing. The state of the art. Chest. 1979;76:764–70. - PubMed
-
- Amin NM. Tuberculin skin testing. Can it contain the impending tuberculosis epidemic? Postgrad Med. 1994;95:46-52–56. - PubMed
-
- Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med. 2000;161:S221–47. - PubMed
-
- Burke DS. Of postulates and peccadilloes: Robert Koch and vaccine (tuberculin) therapy for tuberculosis. Vaccine. 1993;11:795–804. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials